Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
302.00
Ask:
305.00
Spread: 3.00 (0.993%)
Market Cap: £356.03m
DIG Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Inc. Share Chart

Board Changes

31 Jan 2025 10:43

RNS Number : 4807V
Dunedin Income Growth Inv Tst PLC
31 January 2025
 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier (LEI): 549300PPXLZPR5JTL763

 

 

 

31 January 2025

 

 

Board Changes

The Board of Dunedin Income Growth Investment Trust PLC (the "Company") is pleased to announce the appointment of Arun Kumar Sarwal as an independent non-executive Director of the Company with effect from 1 February 2025. 

 

Arun Kumar Sarwal is a Chartered Accountant and has broad experience of global equities and fund management over some 35 years in the UK, Europe, and Asia. He is a Board Advisor to Tumelo and a director and Chairman of the Audit Committee of JPMorgan European Discovery Trust plc. His previous roles include CEO of Broadridge Fund Communication Solutions, Senior Vice President of SS&C Technologies, COO and CFO at Scottish Widows Investment Partnership and global roles at ABN AMRO and Societe Generale Investment Bank.

 

Arun will stand for election at the Annual General Meeting to be held in May 2025. There are no other disclosures required under Section 6.4.8 of the FCA's Listing Rules in relation to this appointment.

 

As previously stated, Jasper Judd and David Barron, who both joined the Board in February 2016 will retire as Directors at the conclusion of the Company's Annual General Meeting in May. It is the Board's intention that Arun Kumar Sarwal will be appointed as Chairman of the Audit Committee in place of Jasper Judd at that time. As previously stated, Howard Williams, who has been a Director since April 2018, will succeed David Barron as Chair of the Company following the AGM.

 

It is the Board's intention to recruit a further Director in 2025 to bring the number of Directors back to five.

 

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKDBQKBKDBDN
Date   Source Headline
4th Mar 20255:26 pmRNSTransaction in Own Shares
4th Mar 202512:45 pmRNSNet Asset Value(s)
3rd Mar 20255:20 pmRNSTransaction in Own Shares
3rd Mar 20253:47 pmRNSGearing disclosure
3rd Mar 20259:46 amRNSTotal Voting Rights
28th Feb 20255:08 pmRNSTransaction in Own Shares
28th Feb 20251:00 pmRNSNet Asset Value(s)
27th Feb 20255:27 pmRNSTransaction in Own Shares
27th Feb 202511:47 amRNSNet Asset Value(s)
26th Feb 20255:15 pmRNSTransaction in Own Shares
26th Feb 202512:27 pmRNSNet Asset Value(s)
25th Feb 20255:25 pmRNSTransaction in Own Shares
25th Feb 202512:19 pmRNSNet Asset Value(s)
24th Feb 20255:10 pmRNSTransaction in Own Shares
24th Feb 20252:54 pmRNSGearing disclosure
24th Feb 202512:58 pmRNSNet Asset Value(s)
21st Feb 20255:11 pmRNSTransaction in Own Shares
21st Feb 202512:15 pmRNSNet Asset Value(s)
20th Feb 20255:15 pmRNSTransaction in Own Shares
20th Feb 202512:05 pmRNSNet Asset Value(s)
19th Feb 20255:14 pmRNSTransaction in Own Shares
19th Feb 202512:56 pmRNSNet Asset Value(s)
18th Feb 202512:44 pmRNSNet Asset Value(s)
17th Feb 20255:16 pmRNSTransaction in Own Shares
17th Feb 202512:59 pmRNSGearing disclosure
17th Feb 202512:46 pmRNSNet Asset Value(s)
17th Feb 20259:47 amRNSCompliance with Market Abuse Regulation
14th Feb 20255:18 pmRNSTransaction in Own Shares
14th Feb 202512:23 pmRNSNet Asset Value(s)
13th Feb 20255:23 pmRNSTransaction in Own Shares
13th Feb 202512:14 pmRNSNet Asset Value(s)
13th Feb 202512:13 pmRNSPortfolio disclosure
12th Feb 20255:23 pmRNSTransaction in Own Shares
12th Feb 202512:34 pmRNSNet Asset Value(s)
11th Feb 20255:11 pmRNSTransaction in Own Shares
11th Feb 202512:21 pmRNSNet Asset Value(s)
10th Feb 20255:13 pmRNSTransaction in Own Shares
10th Feb 20253:14 pmRNSGearing disclosure
10th Feb 20251:10 pmRNSNet Asset Value(s)
7th Feb 20255:15 pmRNSTransaction in Own Shares
7th Feb 202511:49 amRNSNet Asset Value(s)
6th Feb 20255:17 pmRNSTransaction in Own Shares
6th Feb 20252:37 pmRNSMonth End Net Asset Value(s)
6th Feb 202512:55 pmRNSNet Asset Value(s)
5th Feb 20255:24 pmRNSTransaction in Own Shares
5th Feb 202511:55 amRNSNet Asset Value(s)
4th Feb 20255:18 pmRNSTransaction in Own Shares
4th Feb 20254:42 pmRNSQuarterly disclosure
4th Feb 202512:47 pmRNSNet Asset Value(s)
3rd Feb 20255:20 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.